MNTR News Alert Mentor Capital Inc. (MNTR) 0.8750 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mentor Capital Inc. (MNTR) 0.8750 $MNTR

Mentor Capital and Cannabis Edibles on Cover of Food & Drink
Business Wire - Tue Sep 09, 11:17AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced it is pleased to be on the cover and featured in the "Budding Opportunities" Fall 2014 edition of Food & Drink which explores the "emerging world of cannabis edibles." Over a range of topics and in plain terms, the article explains how and how much heating of marijuana by smoking or baking activates the psychoactive THC. This gave birth to the joint and the magic brownies of the 60's. These mainstays are now being updated with vape systems and cannabis infused edible products. Similarly, the tried and true process of extracting the active marijuana oils by making cannabutter on the stove top is described. Here, the most modern approach is to now use liquefied CO2 at 1,000 atmospheres which also dissolves oils. Reducing the pressure releases the gas leaving only the very pure cannabis extract behind.

Mentor Capital Discusses Cannabis Investing at The MoneyShow
ACCESSWIRE - Wed Aug 20, 10:06AM CDT
Generic Marijuana Stock Tips to be Covered Friday at San Francisco Show

Mentor Capital Sues Bhang Corp. and Owners for Return of $1.5M
Business Wire - Mon Aug 11, 7:10PM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has filed suit for rescission against marijuana edibles company Bhang Chocolate Company, Inc. and its owners in the United States District Court for the Northern District of California. Mentor Capital seeks the return of the $1.5 million paid to defendants plus interest for these monies paid to Bhang and required by contract to be paid directly to Bhang's owners, Mr. Scott Van Rixel, Mr. Richard Sellers, and Mr. William Waggoner. The defendants have failed to perform and continue to refuse to perform their obligations under the contract between Bhang and Mentor Capital dated February 28, 2014.

Mentor Capital declares second repurchase of 300,000 common stock
M2 - Mon Aug 11, 7:17AM CDT
A company that seeks to invest in cannabis companies, Mentor Capital Inc (OTC Markets:MNTR) announced on Friday that it is initiating the second repurchase of 300,000 shares of its currently outstanding common stock.

Mentor Capital Announces Second Stock Buyback
Business Wire - Fri Aug 08, 10:46AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) is initiating the repurchase of 300,000 shares of its currently outstanding common stock. The repurchase will be funded by the commitment of approximately 5% of the company's cash and cash-like current assets which are specifically identified and reserved. Mentor Capital's first stock repurchase plan of 100,000 shares was fully executed and completed in December 2013. It is the company's policy to fully execute any stock repurchase plan announced.

Mentor Capital Issues First Half Financials with $1.0 M Revenue
Business Wire - Tue Aug 05, 9:27AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced its first half consolidated operating results today in preparation to audit submission. The complete financial filing can be viewed at the company's Filings and Disclosure page at the OTCMarkets.com website under the Mentor Capital ticker (MNTR).

Mentor Capital Proposes to Accept and Dividend $1.8 Million in Bhang Stock to Shareholders
Business Wire - Mon Aug 04, 2:55PM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) reports that Bhang Corporation owners, Mr. Scott Van Rixel (67.5%), Mr. Richard Sellers (30%), and Mr. William Waggoner (7.5%) have received $1.5 million from Mentor Capital without returning value for Mentor's shareholders and while repudiating their agreement with Mentor. It appears that the Bhang owners intend to keep the $1.5 Million, and give Mentor and its shareholders nothing in return.

Mentor Capital's MicroCannaBiz Sees Revenues in Fourth Month
Marketwire - Fri Jun 13, 1:05PM CDT
Mentor Capital, Inc. (OTC Pink: MNTR) (PINKSHEETS: MNTR) announced today that its portfolio subsidiary MicroCannaBiz, LLC, has transitioned from start-up to revenue generation. With initial and expansion funding provided by Mentor Capital, MicroCannaBiz was formed in February to address the legal cannabis market by Financial Research Solutions, Inc., a media, microcap investment research and educational training company.

Mentor Capital Targets $100 Million for Marijuana Investments from Call of Series D Warrants
Business Wire - Wed Mar 12, 11:49AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it is Calling its 15 Million Series D ($7) warrants at their long-standing strike price of $7.00 per share, and in this fashion targets to raise $100 Million for marijuana related investments. These warrants are already in the hands of Mentor Capital's original 1,500 mostly accredited investors. The call period is through June 30th, 2014.

Mentor Capital Acquires 60% of Bhang Chocolate for $39 Million
Business Wire - Tue Mar 11, 11:11AM CDT
Mentor Capital, Inc. (OTC Markets: MNTR) announced today that it has been selected by Bhang Chocolate Company, Inc. to provide $39 Million in equity funding for Bhang's national and international expansion and to help further extend their market-leading brand across the marijuana related sector. Mentor Capital CEO, Chet Billingsley, affirms, "By a wide margin, five time cannabis cup winner, Bhang Chocolate is recognized as the world's singular leading cannabis brand. We feel privileged to be working with the Bhang management team lead by founder Scott Van Rixel. In the explosively growing and sometimes chaotic environment accompanying marijuana legalization, they provide a bulwark of business professionalism and integrity in the delivery of Bhang's gourmet medicinal chocolates and growing infused edible selections."

WEALTHMAKERS.COM Issues Report on Mentor Capital
M2 - Mon Mar 10, 8:54AM CDT
March 10, 2014 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Mentor Capital (OTC: MNTR). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $2.54 and the projected short squeeze price target of $19.59 per share.

Mentor Capital Catches Market Makers Selling 250% of Shares
Marketwire - Tue Feb 25, 11:50AM CST
Mentor Capital, Inc. (OTC Pink: MNTR) announces that BuyIns.Net has uncovered that Shorts have sold 5.5 Million of the 2.2 Million (sic.) Mentor Capital, Inc. shares in the float and available to trade. In response to this situation, Mentor Capital Inc.'s CEO, Chet Billingsley comments, "For 2014 we retained BuyIns.Net, who monitors all stock trades for illegal short selling activity, soon after 50% of our float suspiciously traded in two hours." According to his web site, BuyIns.Net founder, Tom Ronk, entered into a business partnership with former SEC Chairman, Harvey Pitt. They spearheaded the passage of Regulation SHO that, if followed, helps safeguard public companies from these sorts of short selling issues.

BUYINS.NET Issues Mentor Capital SqueezeTrigger Report
M2 - Tue Feb 25, 2:34AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Mentor Capital (OTC: MNTR) after releasing the latest short sale data through February 21, 2014. The total aggregate number of shares shorted since August 2009 is approximately 3.45 million shares. Approximately 41.09% of daily trading volume is short selling. The SqueezeTrigger price for all MNTR shares shorted is $1.53. A short squeeze has just begun as shares of MNTR closed above the $1.53 SqueezeTrigger price.

Mentor Capital Acquires 51% Stake in MicroCannaBiz, LLC
Business Wire - Thu Feb 20, 12:54PM CST
Mentor Capital, Inc. (OTC Markets: MNTR) announced today that it has acquired a 51% equity interest in MicroCannaBiz, LLC, which was recently formed to address the legal cannabis market by Financial Research Solutions, Inc., a media, microcap investment research and educational training company.

Mentor Capital Agrees to $2M Backing for Cannabis Advocacy Business
Business Wire - Mon Jan 27, 7:30AM CST
Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has agreed to provide $2 Million in funding for The Cannabis Advocacy Machine. Mentor Capital CEO, Chester Billingsley, explains that behind any political initiative there is a commercial enterprise in the business of developing data and statistics, directing advertisement, and maintaining proprietary software systems. The Cannabis Advocacy Machine, a division of The Machine Corporation, is providing Moneyball-like direction and support that is key to that process for the legalization of cannabis across the country. "Signing a letter of intent for 20% of The Machine Corporation under the nationally experienced leadership of the first tier team with Joe Brezny, aims to accelerate the legislative initiatives critical to the lifting of marijuana prohibition, in what may be a surprisingly profitable manner."

Mentor Capital Cannabis Index Up 325% in First Three Weeks of 2014
Business Wire - Wed Jan 22, 10:25AM CST
Mentor Capital, Inc. (OTCMKTS:MNTR) reports that its proprietary Cannabis Index appreciated 325% during the first three weeks of 2014. The overall positive and profitable experience for marijuana based businesses and taxing authorities alike is thought to be a key driver in this sector-wide advance.

Mentor Capital Cancer Immunotherapy Index Up 97% in 2013
Business Wire - Tue Jan 21, 10:01AM CST
Mentor Capital, Inc. (OTCMKTS:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 97.4% during 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked against the appreciation of the average of the NASDAQ, S&P, and NYSE Biotech Indices. For the same 2013 annual period the biotech indices averaged a 54.8% gain.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 26

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading

Top 5 Most Recently Viewed Articles

NuCana Discontinues Phase 2 Colorectal Cancer Study

Updated Category News Views 146

NuCana Provides Update on Phase 2 Randomized Colorectal Cancer Study NuTide:323 Study Discontinued Following Initial Analysis Ongoing Studies Show Promise with NUC-7738 and Pembrolizumab NuCana plc (NASDAQ: NCNA) has shared important updates about its clinical trials focused on innovative treatments for colorectal cancer. The company has made the decision to discontinue...

Continue Reading
Brøndbyernes IF Football Meeting - Key Highlights Recap

Updated Category News Views 179

Overview of the Annual General Meeting for Brøndbyernes IF Football A/S BRØNDBYERNES I.F. FODBOLD A/S CVR-nr. 83 93 34 10 This report summarizes the outcomes of the annual general meeting conducted by Brøndbyernes IF Football A/S. Key Date and Location The annual shareholders meeting took place, gathering stakeholders and shareholders at the club's headquarters. A...

Continue Reading
Uncovering the Wealth from Investing in BlackRock

Updated Category News Views 314

The Potential Growth of $1000 in BlackRock Investors often wonder how their money would grow over time if invested in strong companies. Recently, we looked into BlackRock, Inc., known by its stock ticker BLK. Over a span of 15 years, investing just $1000 into BlackRock stocks would yield an impressive value today. According to current evaluations, if you had made that...

Continue Reading
Zealand Pharma Advances Glepaglutide Approval for SBS Treatment

Updated Category News Views 267

Glepaglutide Submission to EMA Marks Significant Progress Zealand Pharma A/S, a pioneering biotechnology company, has recently shared exciting news about its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its innovative drug, glepaglutide. This long-acting GLP-2 analog is specifically designed for treating adults suffering from short...

Continue Reading
Seven Gables Real Estate Partners with Local Logic for Insights

Updated Category News Views 40

Seven Gables Real Estate Partners with Local Logic In a significant move that underscores their dedication to innovation, Seven Gables Real Estate has announced an exciting partnership with Local Logic, a leader in location intelligence. This collaboration is set to incorporate Local Logic's cutting-edge products—Local Content, Local Search, and NeighborhoodWrap—into...

Continue Reading